C63467Level 3

Regimen Used to Treat Bladder Carcinoma

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** Any regimen that can be used for the treatment of bladder carcinoma.

GET/api/v1/systems/nci_thesaurus/nodes/C63467

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

C11956M-CAVI Regimen

C134622Cisplatin/Methotrexate Regimen

C156265Fluorouracil/Mitomycin Regimen

C156266Gemcitabine/Cisplatin/Everolimus Regimen

C158079GTP Regimen

C159436Dose-dense MVAC-Growth Factor Regimen

C159996BCG Regimen

C160138Valrubicin Regimen

C173973Sacituzumab Govitecan Regimen

C188464Cisplatin/Durvalumab/Gemcitabine Regimen

C189872Intravesical Gemcitabine/Mitomycin Regimen

C192217Nadofaragene Firadenovec Regimen

C198502Intravesical Epirubicin Regimen

C198879Intravesical Docetaxel Regimen

C203692Enfortumab Vedotin/Pembrolizumab Regimen

C203975Cisplatin/Gemcitabine/Nivolumab Followed by Nivolumab Regimen

C204398Intravesical Docetaxel/Gemcitabine Regimen

C204761Doxorubicin/Gemcitabine/Ifosfamide Regimen

C205518Intravesical Nogapendekin Alfa Inbakicept/BCG Regimen

C205519Intravesical Mitomycin Regimen

C205606Doxorubicin/Ifosfamide Alternating with Cisplatin/Etoposide Regimen

C206071Intravesical Gemcitabine Regimen

C213432Cisplatin/Gemcitabine/Nivolumab and Recombinant Human Hyaluronidase Regimen

C218397SR Mitomycin Intravesical Solution Regimen

C223266Berahyaluronidase Alfa and Pembrolizumab/Enfortumab Vedotin Regimen

C63486MVAC Regimen

C9717MCV Regimen

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue